Robust algorithm for systematic classification of malaria late treatment failures as recrudescence or reinfection using microsatellite genotyping

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 10, 2015, Pages 6096-6100

  Plucinski, Mateusz M ^a,b   Morton, Lindsay ^a   Bushman, Mary ^a,c   Dimbu, Pedro Rafael ^d   Udhayakumar, Venkatachalam ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Malaria Initiative   (United States)

^c EMORY UNIVERSITY   (United States)

^d Ministry of Health   (Angola)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; PIPERAQUINE; MICROSATELLITE DNA;

ALGORITHM; ANGOLA; ARTICLE; BAYES THEOREM; CLASSIFICATION ALGORITHM; DISEASE CLASSIFICATION; DRUG TREATMENT FAILURE; ETHIOPIA; GENOTYPE; MALARIA; MALARIA CONTROL; MICROSATELLITE MARKER; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; REINFECTION; GENETICS; HUMAN; MONTE CARLO METHOD; TREATMENT OUTCOME;

ALGORITHMS; ANTIMALARIALS; GENOTYPE; HUMANS; MALARIA; MICROSATELLITE REPEATS; MONTE CARLO METHOD; TREATMENT OUTCOME;

EID: 84942852996     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00072-15     Document Type: Article

References (17)

1. World Health Organization. 2013. World malaria report. World Health Organization, Geneva, Switzerland.
2. Mita T, Tanabe K, Kita K. 2009. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 58:201-209. http://dx.doi.org/10.1016/j.parint.2009.04.004.
3. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. 2002. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2:209-218. http://dx.doi.org/10.1016/S1473-3099 (02) 00239-6.
4. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl JMed 361:455-467. http://dx.doi.org/10.1056/NEJMoa0808859.
5. World Health Organization. 2009. Methods for surveillance of antimalarial drug efficacy. World Health Organization, Geneva, Switzerland.
6. World Health Organization. 2008. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. World Health Organization, Geneva, Switzerland.
7. Anderson T, Su X, Bockarie M, Lagog M, Day K. 1999. Twelve microsatellite markers for characterization of Plasmodium falciparum fromfinger-prick blood samples. Parasitology 119:113-125. http://dx.doi.org/10.1017/S0031182099004552.
8. Greenhouse B, Dokomajilar C, Hubbard A, Rosenthal PJ, Dorsey G. 2007. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. Antimicrob Agents Chemother 51:3096-3103. http://dx.doi.org/10.1128/AAC.00159-07.
9. Greenhouse B, Myrick A, Dokomajilar C, Woo JM, Carlson EJ, Rosenthal PJ, Dorsey G. 2006. Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. Am J Trop Med Hyg 75:836-842.
10. Stepniewska K, White NJ. 2006. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Malar J 5:127. http://dx.doi.org/10.1186/1475-2875-5-127.
11. Slater M, Kiggundu M, Dokomajilar C, Kamya MR, Bakyaita N, Talisuna A, Rosenthal PJ, Dorsey G. 2005. Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. Am J Trop Med Hyg 73:256-262.
12. Juliano JJ, Gadalla N, Sutherland CJ, Meshnick SR. 2010. The perils of PCR: can we accurately correct antimalarial trials? Trends Parasitol 26:119-124. http://dx.doi.org/10.1016/j.pt.2009.12.007.
13. Hwang J, Alemayehu BH, Reithinger R, Tekleyohannes SG, Teshi T, Birhanu SG, Demeke L, Hoos D, Melaku Z, Kassa M. 2013. In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia. PLoS One 8:e63433. http://dx.doi.org/10.1371/journal.pone.0063433.
14. Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V. 2015. Efficacy of artemether-lumefantrine and dihydroartemisininpiperaquine for the treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, Angola. Antimicrob Agents Chemother 59:437-443. http://dx.doi.org/10.1128/AAC.04181-14.
15. Gelfand AE, Hills SE, Racine-Poon A, Smith AF. 1990. Illustration of Bayesian inference innormal data models using Gibbs sampling. J AmStat Assoc 85:972-985. http://dx.doi.org/10.1080/01621459.1990.10474968.
16. Simpson EH. 1949. Measurement of diversity. Nature 163:688. http://dx.doi.org/10.1038/163688a0.
17. Shaukat AM, Gilliams EA, Kenefic LJ, Laurens MB, Dzinjalamala FK, Nyirenda OM, Thesing PC, Jacob CG, Molyneux ME, Taylor TE. 2012. Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment. Malar J 11:207. http://dx.doi.org/10.1186/1475-2875-11-207.